The present study found that decreased YTHDF2 expression had poor OS in ccRCC patients with lower TNM stage, higher age, non-distant metastasis, non-lymph node metastasis, female gender, and higher histological grade. This evidence concerns the gene YTHDF2 and metastatic malignant neoplasm in the lymph nodes.